Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Journal of Thrombosis and Haemostasis : JTH|June 24, 2011
Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiationL A Parunov, O A Fadeeva, A N Balandina, et al.Blood|October 1, 1996
Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia BK M Brinkhous, J L Sigman, M S Read, et al.Blood|August 23, 2003
Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogsKaren E Russell, Eva H N Olsen, Robin A Raymer, et al.Thrombosis and Haemostasis|February 19, 2008
Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulationThomas R Meier, Daniel D Myers, Shirley K Wrobleski, et al.Journal of the American College of Cardiology|July 10, 2007
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population StudyMarijn C Meuwese, Erik S G Stroes, Stanley L Hazen, et al.Journal of Medicinal Chemistry|January 5, 2007
2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonistsNeelu Kaila, Kristin Janz, Adrian Huang, et al.Blood|March 22, 2003
Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP)Eva H N Olsen, Arlene S McCain, Elizabeth P Merricks, et al.Journal of Medicinal Chemistry|August 20, 2010
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injuryAdrian Huang, Alessandro Moretto, Kristin Janz, et al.The Journal of Pharmacology and Experimental Therapeutics|December 14, 2005
Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogsJames K Hennan, Robert E Swillo, Gwen A Morgan, et al.The Journal of Pharmacology and Experimental Therapeutics|November 21, 2007
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosisPatricia W Bedard, Valerie Clerin, Natalia Sushkova, et al.Pageof 12